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Interaction of Cortactin and N-WASp
with Arp2/3 Complex
(ARPC1–5) [2]. Alone, Arp2/3 complex is inactive; activa-
tion requires binding of another cellular protein. Upon
activation, Arp2/3 complex binds to the side of a preex-
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The best-characterized activators of Arp2/3 complex2 Department of Microbiology and Cancer Center
University of Virginia Health Sciences Center are members of the Wiskott-Aldrich Syndrome protein
(WASp) family [2]. This family includes WASp, which isCharlottesville, Virginia 22908
expressed in hematopoietic cells, and SCAR/WAVE1–3
and N-WASp, which are expressed ubiquitously. WASp
family members bind Arp2/3 complex via a C-terminalSummary
acidic (A) domain containing a conserved tryptophan
residue. The C terminus also contains a verprolin homol-Background: Dynamic actin assembly is required for
ogy and connecting (VC) domain, which binds mono-diverse cellular processes and often involves activation
meric actin and is important for nucleation activity [2].of Arp2/3 complex. Cortactin and N-WASp activate
Other recently identified Arp2/3 activators include cor-Arp2/3 complex, alone or in concert. Both cortactin and
tactin in mammals, Listeria monocytogenes ActA, CAR-N-WASp contain an acidic (A) domain that is required
MIL in Dictyostelium, Abp1p and Pan1p in buddingfor Arp2/3 complex binding.
yeast, and type I myosin in fission yeast, all of whichResults: We investigated how cortactin and the consti-
bind Arp2/3 complex via an acidic domain similar to thattutively active VCA domain of N-WASp interact with
found in WASp [2].Arp2/3 complex. Structural studies showed that cortac-
The multiplicity of Arp2/3 activators raises two relatedtin is a thin, elongated monomer. Chemical crosslinking
questions. First, how do various Arp2/3 activators bindstudies demonstrated selective interaction of the Arp2/3
to the complex to cause its activation, and, second, howbinding NTA domain of cortactin (cortactin NTA) with
are the signals from different Arp2/3 activators inte-the Arp3 subunit and VCA with Arp3, Arp2, and ARPC1/
grated? Arp2/3 complex alone is inactive, and activationp40. Cortactin NTA and VCA crosslinking to the Arp3
apparently requires a large conformational change [4,subunit were mutually exclusive; however, cortactin
5]. SCAR1/WAVE1 and ActA have been chemicallyNTA did not inhibit VCA crosslinking to Arp2 or ARPC1/
crosslinked to the Arp2, Arp3, and ARPC1/p40 subunitsp40, nor did it inhibit activation of Arp2/3 complex by
of Arp2/3 complex, which suggests that these subunitsVCA. We conducted an experiment in which a saturating
may transduce the switch to the active conformationconcentration of cortactin NTA modestly lowered the
[6]. Activation of Arp2/3 complex is also promoted bybinding affinity of VCA for Arp2/3; the results of this
its binding to the side of an actin filament. The additionexperiment provided further evidence for ternary com-
of actin filaments increases the rate of Arp2/3 complexplex formation. Consistent with a common binding site
activation by WASp/SCAR proteins [7, 8]. An antibodyon Arp3, a saturating concentration of VCA abolished
to the ARPC1/p34 subunit of Arp2/3 complex inhibitsbinding of cortactin to Arp2/3 complex.
binding of the complex to the side of actin filamentsConclusions: Under certain circumstances, cortactin
and reduces the efficiency of nucleation [9]. Activationand N-WASp can bind simultaneously to Arp2/3 com-
of Arp2/3 complex by cortactin and Abp1p appears toplex, accounting for their synergy in activation of actin
involve bridging Arp2/3 complex to actin filamentsassembly. The interaction of cortactin NTA with Arp2/3
[10–12].complex does not inhibit Arp2/3 activation by N-WASp,
Cortactin is a major src kinase substrate and F-actindespite competition for a common binding site located
binding protein [13] that is overexpressed in a numberon the Arp3 subunit. These results suggest a model in
of epithelial carcinomas, including breast cancer andwhich cortactin may bridge Arp2/3 complex to actin
head and neck cancer [14]. Overexpression of cortactinfilaments via Arp3 and N-WASp activates Arp2/3 com-
increases the number of breast cancer metastases inplex by binding Arp2 and/or ARPC1/p40.
nude mice [15] and increases the motility of cultured
fibroblasts [16]. Cortactin binds to Arp2/3 complex via
Introduction its N terminus, to F-actin via its central repeats domain,
and to a number of signaling molecules, including src
Cell migration, vesicle movement, and many other cellu- kinases, Shank, CortBP, ZO-1, and dynamin, via its C-ter-
lar processes require rapid induction of actin polymer- minal proline-rich and SH3 domains [17]. In cells, cortac-
ization [1]. Nucleation of actin to form new filaments tin is targeted to sites of active actin assembly by Rac1
often occurs by activation of Arp2/3 complex, a seven- [18] and colocalizes with Arp2/3 complex in lamellipodia
protein complex containing two actin-related proteins [18, 19] and in the actin comet tails of vesicles [19, 20].
(Arp2 and Arp3) and five unrelated polypeptides Cortactin also localizes to many of the same sites as
N-WASp, including vesicles [19–21] and podosomes [22,
23]. Finally, N-WASp and cortactin apparently form a3 Correspondence: jcooper@cellbio.wustl.edu
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Table 1. Physical Parameters of Cortactin
Ellipsoid Models R Stokes
s*Mass f/f0 Prolate Oblate Vel sed Gel Filtration
kDa S4,w S20,w
63.5 2.09 3.315 1.8 293 A˚a 144 A˚a 48 A˚ 59 A˚
29 A˚b 12 A˚b
a Major lengths of ellipsoid models calculated from the experimental data sets.
b Minor lengths of ellipsoid models calculated from the experimental data sets.
molecular complex in src-transformed cells and are both an asymmetric, elongated molecule [27]. A prolate (ci-
gar-shaped) ellipsoid model of cortactin gives a lengthimportant for the formation of certain actin-rich struc-
tures, such as podosomes [23] and enteropathogenic to width ratio of 10:1 (Table 1). Gel filtration chromatog-
raphy of cortactin yielded a single peak, with a StokesE. coli-induced pedestals [24, 25].
Cortactin binds and activates Arp2/3 complex [10, 11, radius of 59 A˚ (Table 1; also see the Supplementary
Material), slightly larger than the Stokes radius of 48 A˚18]. Cortactin also stabilizes Arp2/3-induced branched
actin networks and inhibits their disassembly [10]. In determined by sedimentation velocity. Both measure-
ments of the Stokes radius are substantially larger thanprevious studies, activation of Arp2/3 complex by cor-
tactin was additive or even synergistic with the constitu- would be expected for a globular protein of molecular
mass 63.5 kDa. For example, bovine serum albumintively active VCA domain of N-WASp (VCA) [10, 11]. Both
cortactin and N-WASp have a single acidic (A) domain, (BSA), a relatively spherical protein with a similar molec-
ular mass (66 kDa) has a Stokes radius of 36 A˚. The largewhich is involved in Arp2/3 binding. Thus, one might
expect that cortactin and N-WASp would compete for Stokes radius and high frictional coefficient indicate that
the cortactin monomer has an asymmetric shape.binding to Arp2/3 complex; however, this simple view
appears to be inconsistent with the apparent synergy “Deep etch” electron microscopy [28, 29] of cortactin
(Figure 1) showed it to be a slender threadlike molecule,between cortactin and N-WASp VCA with respect to
Arp2/3 activation. To address this paradox, we have
now investigated how cortactin and N-WASp VCA inter-
act with Arp2/3 complex, using physical and functional
assays. The results indicate that cortactin and VCA com-
pete for binding to the Arp3 subunit but may still simulta-
neously bind Arp2/3 complex because VCA also binds
to the Arp2 and ARPC1/p40 subunits. The N-WASp VCA
in this ternary complex is fully functional in its ability to
activate Arp2/3 complex, and this provides a model for
how cortactin and N-WASp interact with Arp2/3 complex
to promote actin assembly.
Results
Cortactin Is an Elongated Flexible Monomer
To understand how cortactin interacts with Arp2/3 com-
plex and actin filaments, we first determined the shape
and size of cortactin. Previous studies suggested that
cortactin may be a multimer [11, 26]. We determined
the native molecular mass of cortactin by equilibrium
sedimentation (Table 1; also see the Supplementary Ma-
terial available with this article online). A molecular mass
of 63.5 kDa was calculated from the experimentally de-
termined effective reduced molecular weight () and
Figure 1. Deep Etch Electron Microscopy
from a partial specific volume of 0.7074. The molecular
These images are ideally viewed with red-green (left-right) three-weight predicted from the amino acid sequence is 61.5
dimensional glasses. Rows 1 and 2: individual cortactin molecules
kDa. Thus, under these conditions, recombinant cortac- from a very low-angle (6), relatively “grainy” platinum replica, em-
tin, which binds and activates Arp2/3 complex, is primar- ployed to highlight such very thin molecules. The first image in the
top left corner shows an image before digital post-processing intoily a monomer. Consistent with this result, we have not
a three-dimensional masked image (compare to the adjacent imageobserved actin filament bundling activity with our prepa-
on the right). Row 3: possible associations of Arp2/3 complexesrations of cortactin [10].
with the ends of cortactin molecules, from a standard 12 replica.Sedimentation velocity experiments were performed
Row 4: (Left two panels): F-actin “branchpoints” provided for scale,
to determine the hydrodynamic properties of cortactin generated in a VCA  Arp2/3  G-actin-stimulated polymerization
(Table 1; also see the Supplementary Material). The fric- experiment; (Right two panels): Arp2/3 molecules alone, without
cortactin.tional coefficient for cortactin (f/f0) is 1.8, consistent with
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with a width close to the resolution limit of the platinum
that was used to replicate the molecules after freeze
drying. This platinum forms 20 A˚ beads in such a rep-
lica. We also occasionally saw larger threads that proba-
bly represented self-associated or aggregated cortac-
tin. When mixed with Arp2/3 complex, cortactin was
seen as a slender thread attached at one end to Arp2/3
complex, a formation that is consistent with the previous
identification of the Arp2/3 binding site near the N termi-
nus of cortactin. We were not able to visualize cortactin
bound to actin filaments or at filament branch points,
probably because cortactin is much thinner than the
actin filaments. The average length of optimally repli-
cated cortactin molecules was 220  30 A˚ (mean  SD,
n  91), which is slightly shorter than the 290 A˚ length
predicted by elliptical modeling of the results of the
velocity sedimentation studies (Table 1, prolate model).
Collectively, these hydrodynamic and imaging studies
indicate that cortactin is a monomeric, elongated protein
with a length of 220–290 A˚.
Chemical Crosslinking Studies: How Cortactin
and N-WASp Interact with the Subunits
of Arp2/3 Complex
To identify the subunits within Arp2/3 complex that may
provide binding interfaces with cortactin and VCA,
chemical crosslinking studies were performed. Purified
Arp2/3 complex was incubated with the zero-length
crosslinker EDC/NHS in the presence of GST-VCA or
the N-terminal Arp2/3 binding domain of cortactin (NTA).
Crosslinked products were identified by Western blot-
ting, by using antibodies specific for individual subunits
Figure 2. Chemical Crosslinking Analysis of Cortactin NTA andof Arp2/3 complex. We used a range of protein concen-
GST-VCA to Arp2/3 Complextrations to define the relative importance and specificity
Purified cortactin NTA (0–5 M) or GST-VCA (0–2.5 M) were incu-of the crosslinked products. At protein concentrations
bated with Arp2/3 complex and crosslinked for 30 min. Western
close to the Kd for binding to Arp2/3 complex [11], VCA blots were probed by using antibodies against individual Arp2/3
crosslinked to the Arp3, Arp2, and ARPC1/p40 subunits complex subunits as indicated. The uncrosslinked subunits are the
(Figure 2). These subunits have been reported to bind major, lower band in each case. Crosslinked products, if present,
are indicated as “xN” (for NTA) and “xV” (for VCA). These blots wereto the Arp2/3 activators Scar and ActA [6]. At higher
purposely overexposed in order to see faint crosslinking bands.concentrations, a faint crosslinking product with
n  3.ARPC2/p34 was also observed.
Cortactin NTA was crosslinked only to the Arp3 sub-
unit at low cortactin concentrations (Figure 2). Faint Cortactin NTA inhibited crosslinking of GST-VCA to the
crosslinking products were also observed with the Arp2, Arp3 subunit but not to Arp2 or ARPC1/p40 (Figure 3A).
ARPC1/p40, ARPC2/p34, and ARPC3/p21 subunits; In the converse experiment, increasing concentrations
however, these bands were evident only when the cor- of GST-VCA inhibited crosslinking of cortactin NTA to
tactin NTA concentration was at least ten-fold higher Arp3 (Figure 3B). The simplest interpretation of these
than that required for crosslinking to Arp3 and above results is that cortactin NTA and N-WASp VCA compete
the reported Kd for cortactin binding to Arp2/3 complex for binding to the Arp3 subunit. An alternative explana-
[11, 18]. No crosslinking of cortactin or VCA to ARPC5/ tion is that NTA and VCA bind simultaneously and alter
p16 or ARPC4/p20 was observed at any concentration the conformation of Arp2/3 complex in such a way as
(data not shown). Full-length cortactin and GST-NTA to abrogate the chemical crosslinking reaction. This al-
had the same subunit crosslinking pattern as untagged ternative is less likely since crosslinking of VCA or NTA
NTA (data not shown). to Arp3 is lost in both converse experiments; however,
we tested the model further with a physical binding
experiment that did not involve chemical crosslinking.Cortactin Competes with N-WASp VCA for Binding
to Arp3, but Not to Arp2 or ARPC1/p40 In this experiment, we used a quantitative GST pull-
down assay [30] to determine the apparent Kd for VCASince both cortactin NTA and N-WASp VCA crosslinked
to the Arp3 subunit, we asked whether they would compete binding to Arp2/3 complex, in the presence or absence
of saturating cortactin NTA. Arp2/3 complex (50 nM)with each other. Arp2/3 complex (0.5 M) and GST-VCA
(0.2 M) were incubated with increasing concentrations was incubated with increasing concentrations of GST-
VCA coupled to glutathione-agarose (0–8 M), in theof cortactin NTA (0–80 M) and were then crosslinked.
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Figure 4. The Arp2/3 Binding Domain of Cortactin Does Not Inhibit
the Ability of N-WASp VCA to Stimulate Arp2/3-Mediated Nucleation
(A) Cortactin domain structure. The N-terminal acidic domain (NTA)
(amino acids 1–84) is the Arp2/3 binding domain used for competi-
tion studies in (B). The central repeats domain is required for F-actin
binding and activation of Arp2/3 complex, but does not contribute to
Arp2/3 binding.
(B) Competition between VCA and cortactin: pyrene actin polymer-
ization assay. A GST fusion of the VCA fragment of N-WASp was
incubated with Arp2/3 complex in the presence or absence of the
Arp2/3 binding domain of cortactin (Cort-NTA) in polymerization
buffer for 10 min at 25C. Actin polymerization was initiated by
the addition of monomeric actin (7.5% pyrene labeled) and was
monitored by continuous measurement of fluorescence at 386 nm.
Curves had 12.5 nM Arp2/3 complex  0.5 nM GST-VCA with the
following additions: (b) no additions, (c) 2 M GST-NTA, (d) 11 M
GST-NTA, and (e) 22 M GST-NTA. Other controls (“Controls”) in-
clude actin alone, Arp2/3 alone, and Arp2/3  22 M GST-NTA.
Activation of Arp2/3 complex with higher concentrations of VCA
(“Arp2/3  12.5 nM VCA”) shows that our competition studies were
done under conditions in which Arp2/3 complex was not saturated
by the GST-VCA. n  4.Figure 3. Cortactin and VCA Compete for Binding to Arp3, but Not
to Arp2 or ARPC1/p40
(A) Effects of NTA on GST-VCA crosslinking to Arp2/3 complex
presence or absence of 30 M cortactin NTA. The cor-subunits. Purified Arp2/3 complex (0.5M) was incubated with GST-
tactin NTA concentration was approximately 25-fold theVCA (0.2 M) in the presence or absence of NTA (5–80 M), as
reported Kd for binding to Arp2/3 complex [11, 18]. Theindicated at the top. Antibody probes (top to bottom): anti-Arp3,
-Arp2, -ArpC1/p40. Uncrosslinked Arp2/3 complex subunits are la- GST-VCA beads were rapidly pelleted, and the superna-
beled “Arp3”, “Arp2”, and “p40”. Crosslinked products are labeled
as “NTAx” or “GST-VCAx” plus the appropriate Arp2/3 subunit.
n  3.
(B) Effect of GST-VCA on NTA crosslinking to Arp3. Purified Arp2/3 cortactin NTA was determined by supernatant depletion [30]. GST-
complex (0.5 M) was incubated with NTA (1 M) in the presence or VCA-Arp2/3 complex (“Bound VCA”) is shown plotted against the
absence of GST-VCA (0–5 M), as indicated at the top. Crosslinked free GST-VCA concentration (“Free VCA”) (average of three indepen-
products are labeled “NTAxArp3” or “GST-VCAxArp3”. n  3. dent experiments, error bars represent standard error). Apparent Kd
(C) Effect of NTA on the Kd for VCA binding to Arp2/3 complex. values for VCA binding to Arp2/3 complex were 0.76 0.01 M and
Binding of Arp2/3 complex (50 nM) to GST-VCA beads (0–8 M) in 1.21 0.09 M (mean SE), in the absence or presence of cortactin
the absence (solid circles) or presence (open squares) of 30 M NTA, respectively (p  0.05).
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tants were analyzed for depletion of Arp2/3 complex by
Western blotting. From these measurements, we calcu-
lated the amount of Arp2/3 complex associated with the
GST-VCA beads. The concentration of GST-VCA-Arp2/3
complex was plotted against the free GST-VCA concen-
tration, and apparent Kd values were determined by least
squares analysis (Figure 3C). The apparent Kd for VCA
binding to Arp2/3 complex was 0.76  0.01 M and
1.21  0.09 M (mean  SE, n  3), in the absence and
presence of cortactin NTA, respectively. These values
were significantly different (p  0.05). The fact that VCA
does bind Arp2/3 complex in the presence of a saturat-
ing concentration of cortactin provides evidence that a
ternary VCA-Arp2/3-cortactin complex can form and is
consistent with a model in which cortactin blocks only
one of the multiple VCA binding sites within Arp2/3 com-
plex. Competition at this site is apparently sufficient to
decrease the apparent binding constant for the VCA-
Arp2/3 interaction.
When the converse pull-down experiment was per-
formed with GST-NTA beads, a saturating concentration
of VCA (14 M) completely blocked Arp2/3 binding to
the beads (see the Supplementary Material). Therefore,
physical binding studies also support a model in which
cortactin NTA and N-WASp VCA compete for a single
binding site, i.e., Arp3, within Arp2/3 complex, and
N-WASp VCA has additional binding sites.
Cortactin Does Not Inhibit Activation
of Arp2/3 Complex by N-WASp VCA
To test for functional competition between cortactin and
N-WASp VCA, we asked whether cortactin NTA inhibits
the ability of VCA to activate Arp2/3 complex. Cortactin
NTA alone, without the F-actin binding domain, binds
but does not activate Arp2/3 complex [10, 18]. We de-
signed pyrene actin polymerization assays with a subsa-
turating concentration of VCA (0.5 nM) and a low con-
centration of Arp2/3 complex (12.5 nM), to which we
added excess NTA. Concentrations of NTA up to 22 M
did not affect activation of Arp2/3 complex by VCA (Fig-
ure 4). Experiments with both tagged and untagged pro-
teins (VCA with GST-NTA, GST-VCA with NTA, GST-VCA
with GST-NTA) yielded similar results (data not shown).
We calculated that virtually all of the Arp2/3 complex
should have been bound to NTA (calculated for 22 M
NTA), assuming equilibrium conditions and conserva-
tion of mass and using previously determined Kds of
1.0–1.3 M and 0.2–0.75 M for the binding of cortactin
and VCA, respectively, to Arp2/3 complex [11, 18], (Fig-
ure 3C).Figure 5. Effect of VCA Mutations on Arp2/3 Activation and Subunit
Binding
(A) Acidic domain sequences of N-WASp and cortactin with indica- Binding of the VCA DDW Motif to Arp3 Is Not
tions of the mutants used in this study. The asterisks show the point Necessary for Arp2/3 Complex Activation
mutation sites. The apparent competition of cortactin NTA for VCA bind-
(B) Pyrene actin polymerization assay: wild-type or mutant GST-
ing to the Arp3 subunit combined with the lack of func-VCA, as indicated, was added to 12.5 nM Arp2/3 and 2.5 M actin
tional inhibition suggests that binding of VCA to the Arp3in polymerization buffer. Controls included Arp2/3 alone, actin alone,
and each GST-VCA protein alone. n  3.
(C) Crosslinking studies: wild-type or mutant GST-VCA, as indicated,
(0.4 M) was incubated with 0.5 M Arp2/3 complex.
(D) Densitometry analysis of crosslinking results: the degree of wild-type crosslinking (mean standard error for three independent
crosslinking of wild-type or mutant VCAs was evaluated by densi- experiments). The black solid bars represent wild-type GST-VCA,
tometry of films from the subunit-specific Western blots, such as the diagonally hatched bars represent GST-W503A, and the gray
the ones shown in (C). The data are plotted as the percentage of solid bars represent GST-498–505.
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subunit may not be necessary for VCA activation of
Arp2/3 complex. To test this hypothesis, we mutated
the DDW binding motif that is shared with cortactin
(Figure 5A). We truncated the C terminus by eight amino
acids (498–505), thus deleting the DDW motif. In pyrene
actin polymerization assays, 498–505 VCA activated
Arp2/3 complex as well as did wild-type VCA (Figure
5B). This experiment was performed with GST fusions
of VCA; untagged versions also showed no difference
between wild-type and mutant VCAs (data not shown).
To test for interaction of the mutant VCA with the Arp3
subunit, chemical crosslinking was performed. Cross-
linking of the 498–505 VCA to Arp3 was decreased
by 81  7% relative to wild-type VCA. Crosslinking to
ARPC1/p40 was decreased by 37  7%, and crosslink-
ing to Arp2 was not changed (representative blot shown
in Figure 5C, quantitation by densitometry of films from
three separate experiments graphed in Figure 5D). A
VCA mutant in which the conserved tryptophan in the
DDW motif was changed to an alanine (W503A) had
unchanged crosslinking to Arp3, Arp2, or ARPC1/p40
and unchanged activity (Figure 5). It is possible that the
removal of acidic residues from 498–505 VCA affected
the crosslinking of VCA to Arp3 without fully abolishing
the binding of VCA to Arp3. However, these data support
the prediction that the shared DDW motif in VCA and
cortactin is involved in Arp3 binding and that this interac-
tion is not necessary for activation of Arp2/3 complex
Figure 6. Effect of Cortactin Mutation on Binding and Activation ofby N-WASp VCA.
Arp2/3 Complex
(A) Arp2/3 pull-down: Arp2/3 complex binding by cortactin proteins
Mutation of Tryptophan 22 Abolishes Binding was assayed by bead pull-down assays. Cortactin proteins (un-
tagged) or GST (as a negative control) were covalently bound toand Activation of Arp2/3 Complex by Cortactin
Sepharose. Equal volumes of beads were incubated with mouseCortactin binds Arp3 primarily and also has a conserved
brain lysate. Protein bound to the beads was analyzed with an anti-tryptophan as part of a DDW motif in its acidic domain.
Arp3 Western blot. The amount of protein on the beads was asWe tested the importance of this tryptophan in the inter-
follows: cortactin, 80g; cortactin W22A, 160g; cortactin fragment
action of cortactin with Arp2/3 complex. The W22A cor- 1–269, 180 g; cortactin fragment 350–546, 180 g; GST, 40 g;
tactin mutant protein did not bind Arp2/3 complex in a and Beads Only, 0 g. This blot was purposely overexposed in order
to visualize any faint bands. Lanes: cortactin: full-length cortactin;pull-down assay (Figure 6A). Cortactin W22A also did
cortactin W22A: full-length cortactin with a point mutation in thenot activate Arp2/3 complex in a pyrene actin polymer-
Arp2/3 binding domain; cortactin 1–269: amino acids 1–269 of cor-ization assay (Figure 6B). Thus, the conserved trypto-
tactin; cortactin 350–546: amino acids 350–546 of cortactin; GST:phan in the DDW motif is essential for the interaction of
glutathione S-transferase; Brain Lysate: 40 g protein loaded as a
cortactin with Arp2/3 complex. The DDW motif may be control. n  3.
most important for proteins that bind primarily to Arp3. (B) Pyrene actin polymerization assay: 500 nM full-length His-tagged
cortactin or His-tagged W22A mutant cortactin was coincubated
with 100 nM Arp2/3 complex and 2.5 M actin in polymerization
Discussion buffer. n  3.
Model for Binding of Cortactin and N-WASp VCA
to Arp2/3 Complex interaction of N-WASp VCA with the Arp3 subunit, but
not with the Arp2 or ARPC1/p40 subunits. In a physicalCortactin and N-WASp share a common acidic domain
that binds Arp2/3 complex, but they are able to cooper- binding (pull-down) experiment, cortactin caused a
modest decrease in the apparent affinity of VCA forate and even synergize in activating Arp2/3 complex
[10, 11]. Our results here provide an explanation for Arp2/3 complex, but did not prevent the interaction. By
contrast, N-WASp VCA completely blocked both thethis apparent paradox by demonstrating that a ternary
complex between cortactin, Arp2/3 complex, and binding of cortactin to Arp2/3 complex in a pull-down
assay and the chemical crosslinking of cortactin to theN-WASp VCA can form. Cortactin and N-WASp compete
for binding to one subunit, the Arp3 subunit, of Arp2/3 Arp3 subunit.
The interaction of N-WASp VCA with the Arp3 subunit,complex. N-WASp has additional interactions with the
Arp2 and ARPC1/p40 subunits, which are not found with which is competed by cortactin, appears to play little
or no role in the activation of Arp2/3 complex. Ancortactin and are not competed by cortactin (see model
in Figure 7). N-WASp VCA truncation mutant, lacking the DDW motif,
no longer can be crosslinked to Arp3 but activatesThese conclusions are based on several results. In a
chemical crosslinking experiment, cortactin blocked the Arp2/3 complex normally. Also, high concentrations of
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Figure 7. Model of Coactivation by N-WASp
and Cortactin
(A) N-WASp alone binding to the Arp2, p40,
and Arp3 subunits of Arp2/3 complex.
N-WASp (red) is shown bound to Arp2/3 com-
plex (pink) at an actin (aqua) end-to-side
branch point. Also shown are the N-WASp
activators cdc42 and phosphatidylinositol
4,5-bisphosphate (PIP2). The arrangements of
Arp3, Arp2, and ARPC1/p40 are based on
previous crosslinking and structural studies
[4, 5].
(B) N-WASp and cortactin bound to Arp2/3
complex at an actin filament branch point.
Cortactin (dark blue) binds to Arp3 and dis-
places the extreme C-terminal region of
N-WASp. Cortactin is also shown binding ac-
tin filaments via its central repeats domain and a third molecule (“X”), such as dynamin or SHANK, via its SH3 domain. Cortactin is drawn
here as binding the mother filament, but it may bind the daughter filament instead.
cortactin NTA compete away the VCA-Arp3 interaction F-actin, may cause Arp2/3 complex to assume the same
or different conformational states. In other words, thebut have no effect on the activation of Arp2/3 complex
by VCA. Therefore, the interactions of N-WASp VCA with conformational pathway followed by Arp2/3 complex
may differ depending on its interactions with N-WASp,other subunits, namely, Arp2 and ARPC1/p40, may be
more important for activation. cortactin, actin monomers, and actin filaments.
The combination of our chemical crosslinking, bind-
ing, and functional studies indicates that a ternary func-
Integration of Signaling Pathways Directedtional complex of cortactin, N-WASp, and Arp2/3 com-
at Arp2/3 Complexplex can form. In this ternary complex, the F-actin
We found that cortactin is long, thin, and flexible andbinding site of cortactin probably promotes and stabi-
that it exists as a monomer, based on a combination oflizes the interaction of Arp2/3 complex with the mother
structural approaches. Electron micrographs reveal thatactin filament, and N-WASp induces strong activation
one end of cortactin binds Arp2/3 complex, and this isof Arp2/3 complex to nucleate the formation of the
consistent with previous studies localizing the Arp2/3daughter filament. The interaction of cortactin with
binding domain to the N-terminal portion of cortactinArp2/3 complex can be abolished by excess N-WASp
[18]. Together, all our findings are consistent with theVCA, so whether a ternary complex forms in vivo will
idea that cortactin can bind simultaneously to three pro-depend on the microenvironment, including the local
teins — Arp2/3 complex at its N terminus, an actin fila-concentrations of cortactin and activated N-WASp.
ment in its central region, and a third molecule, suchN-WASp and cortactin were coimmunoprecipitated
as dynamin, Shank, CortBP, or ZO-1 [17], via the SH3from lysates of src-transformed fibroblasts [23], consis-
domain near its C terminus. One recent biochemicaltent with the formation of a ternary complex. Immunolo-
study confirms that all three interactions can exist atcalization studies reveal that cortactin and N-WASp co-
the same time (Hou et al., personal communication).localize at certain sites of actin polymerization, such as
In addition to binding a number of signaling proteinspodosomes [23]; however, some actin-rich structures,
at its SH3 domain, cortactin is also a physiologicallysuch as Vaccinia-induced actin tails, contain cortactin
significant substrate for tyrosine phosphorylation by srcbut not N-WASp [31].
kinases [17, 32, 33]. The presence of these multiple
interactions and modifications may allow cortactin to
Mechanisms for Arp2/3 Complex Activation integrate diverse signals directed at Arp2/3 complex.
by Cortactin and N-WASp Signals can also arrive at Arp2/3 complex via N-WASp,
The mechanisms by which cortactin and N-WASp acti- by its activation by PIP2, Cdc42, and Grb2 and/or Nck,
vate Arp2/3 complex and enhance actin assembly are and by its interaction with WIP [2]. The finding that cor-
different. Both bind Arp2/3 complex, but in different tactin and N-WASp can simultaneously bind and coop-
ways. Cortactin binds Arp2/3 complex via Arp3, and erate in activation of Arp2/3 complex suggests that di-
N-WASp binds via Arp3, Arp2, and ArpC1/p40. The DDW verse signals may be integrated at the level of Arp2/3
motif in cortactin is essential for Arp2/3 activation, complex as well.
whereas the same motif in N-WASp VCA is not. N-WASp
binds monomeric actin, enhancing nucleation [2], and
cortactin binds actin filaments, stabilizing actin branch- Conclusions
We investigated the interactions of cortactin andpoints [10].
Structural studies suggest that Arp2/3 complex un- N-WASp with Arp2/3 complex. Cortactin and N-WASp
compete for a common site on the Arp3 subunit;dergoes a major conformational change upon activation
[4, 5]. The number and nature of the conformational N-WASp has additional interactions with the ARPC1/
p40 and Arp2 subunits, which are not competed bystates available to Arp2/3 complex is not known.
N-WASp and cortactin, in combination with G- and cortactin. In cells, diverse signaling pathways that im-
Cortactin, N-WASp, and Arp2/3 Complex
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Chemical Crosslinkingpinge on N-WASp and cortactin may be integrated at
Purified proteins were coincubated in 60 mM KCl, 2 mM MgCl2, 20the level of Arp2/3 complex and actin assembly.
mM HEPES, 0.1 mM ATP, 0.025% Thesit (pH 7.4) for 10 min at 25C
before the addition of 1.5 mM EDC/NHS, added from a fresh 1:1Experimental Procedures
mixture of 100 mM stocks in DMSO (Pierce Chemical Company).
Crosslinking reactions were terminated after 30 min by the additionChemicals
of SDS-PAGE sample buffer, such that the final concentration ofUnless otherwise noted, chemicals and reagents were purchased
Tris was 100 mM. The reactions were analyzed by SDS-PAGE onfrom Sigma Chemical or Fisher Scientific.
vertical slab gels [41]. Using the Mini-Transblot system (BioRad),
proteins were transferred to nitrocellulose membranes. MembranesPlasmid Construction
were blocked overnight in 1% BSA (w/v), 0.1% (v/v) Tween-20 inThe GST-VCA construct was kindly provided by Marie-France Car-
150 mM NaCl, 20 mM NaH2PO4 (pH 7.4), then probed withlier, CNRS, Gif-sur-Yvette, France. Mutation of the GST-VCA [34]
1:20,000–1:500,000 dilutions of affinity-purified Arp2/3 subunit-spe-and GST-cortactin [18] plasmids was performed with the Quik-
cific rabbit antibodies. After washing, blots were then probed withChange Site-Directed Mutagenesis Kit (Stratagene).
1:60,000 dilutions of anti-rabbit-HRP secondary antibodies (Bio-
Source), washed, and developed by Enhanced ChemiluminescenceAntibodies
(Amersham Pharmacia Biotech), with exposure to Hyperfilm (Amer-Polyclonal antibodies directed against Arp3, p41, p16 [35], p34, p21
sham Pharmacia Biotech). Densitometry of the films was performed[36], and Arp2 and p20 [37] were previously described.
with an Epson scanner and NIH Image software.
Protein Purification
Kd Determinations by GST-VCA Pull-DownArp2/3 complex was purified from bovine brain by GST-VCA affinity
of Purified Arp2/3 Complexchromatography [34] or bovine thymus by conventional chromatog-
GST-VCA bound to glutathione-agarose was quantitated by analyz-raphy [8]. In all cases, when compared (in both chemical crosslinking
ing a range of bead volumes along with a standard curve of bovineand pyrene actin polymerization assays), the method of purification
serum albumin by SDS-PAGE, followed by Coomassie staining anddid not affect the experimental results. GST-VCA was purified by
densitometry of the gel (NIH Image). GST-VCA beads (0–8 M) wereglutathione affinity chromatography, as previously described [34].
incubated with 50 nM Arp2/3 complex in the presence or absenceFor the preparation of untagged VCAs, GST-VCA beads were rotated
of 30 M NTA in 60 mM KCl, 2 mM MgCl2, 20 mM HEPES (pHat room temperature for 90 min with 15 U/ml bovine thrombin (Cal-
7.4)  4 mg/ml bovine serum albumin. Glutathione-agarose wasbiochem) in 150 mM NaCl, 2.5 mM CaCl2, 50 mM Tris, 1 mM DTT
also added to various samples so that all of the bead volumes(pH 7.5). The supernatant was collected, and untagged VCAs were
were equivalent. The samples were agitated for 10 min at roomfurther purified by anion exchange chromatography on a Mono-Q
temperature, before centrifugation. The supernatants were col-column (Pharmacia) with a gradient of 30–500 mM NaCl in 10 mM
lected and analyzed by SDS-PAGE, followed by immunoblottingTris, 1 mM EDTA (pH 8.0). Actin was purified from chicken pectoralis
for Arp3, as described above. Depletion of the supernatant wasskeletal muscle [38] and was gel filtered [39]. Full-length and smaller
determined by densitometry of the films (NIH Image), and concentra-domains of cortactin protein were purified from BL21 E. coli by
tions of bound and free VCA were calculated from the amount ofglutathione affinity chromatography followed by GST-tag cleavage
Arp2/3 complex depleted from the supernatant. The binding resultsand removal as previously described [18], followed by anion ex-
were plotted as bound VCA versus free VCA with Kaleidographchange chromatography on a Mono-Q column (Pharmacia) with a
software and were fit by the following equation:gradient of 40–500 mM NaCl in 10 mM Tris, 1 mM EDTA (pH 8.0).
Cortactin proteins were concentrated by rebinding to a Mono-Q [VCAbound]  {(Kd  [Arp2/3]  [VCA]) 	 ((Kd column and then step eluting. Protein concentrations were calcu-
lated from the UV absorption at 280 nm, based on the tryptophan [Arp2/3]  [VCA])2 	 (4•[Arp2/3]•[VCA]))}/2.
and tyrosine content of each protein, except for the untagged VCAs,
Statistical analysis was performed with Kaleidograph software.which were quantitated by UV absorption at 205 nM due to a lack
of tryptophan or tyrosine residues in the mutant VCAs.
Arp2/3 Pull-Downs from Mouse Brain Lysate
Recombinant untagged cortactin proteins or GST were covalentlyElectron Microscopy
linked to CNBr-Sepharose. A 50% suspension (40 l) of beads wasPurified proteins were diluted to 5 g/ml in 70 mM KCl, 3 mM MgCl2,
incubated with 800 l (4.5 mg/ml) of mouse brain lysate for 30 min30 mM HEPES (pH 7.4). Samples were adsorbed to mica flakes at
before washing in 50 mM KCl, 1 mM EDTA, 0.1 mM ATP, 1% NP40,25C, quick frozen, and freeze dried as described [28, 29]. Replicas
20 mM HEPES (pH 7.4), as previously described [18].were observed at 70,000
magnification in a standard transmission
electron microscope operating at 100 kV. Suitable areas were photo-
Supplementary Materialgraphed on film as stereo pairs, by using  10 tilt of the micro-
Supplementary Material including the Experimental Procedures andscope’s goniometer stage, and were converted to digital images at
two figures is available at http://images.cellpress.com/supmat/5
 higher magnification with a Kodak 560 digital copy camera.
supmatin.htm.Stereo pairs were then converted to anaglyphs, and optimally sepa-
rated molecules were selected by hand as 300 
 300 pixel crops
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